$CGTX

Cognition Therapeutics Inc

Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Purchase, NY

CGTX chart

What traders are saying about $CGTX

Latest posts

Cognition Therapeutics Inc news

Cognition Therapeutics Inc key financials

USD2025202420232022
Net income-$23.5M-$34.0M-$25.8M-$21.4M
Diluted EPS$-0.32$-0.86$-0.86$-0.91
Total assets (year end)$48.4M$30.2M$35.2M$50.4M
Cash and equivalents (year end)$36.8M$25.0M$29.9M$41.6M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Cognition Therapeutics Inc

Ticker
CGTX (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Purchase, NY
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1455365
Former names
COGNITION THERAPUTICS INC

Frequently asked questions

What exchange is Cognition Therapeutics Inc listed on?

Cognition Therapeutics Inc trades on the Nasdaq under the ticker symbol CGTX.

What industry is Cognition Therapeutics Inc in?

Cognition Therapeutics Inc is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.

Where is Cognition Therapeutics Inc headquartered?

Cognition Therapeutics Inc's business address on file with the SEC is in Purchase, NY.

When does Cognition Therapeutics Inc's fiscal year end?

Cognition Therapeutics Inc's fiscal year ends on December 31.